ALREX
ALREX
Approved
DIN Number
02320924
Drug Class
Human
Market Date
Jun 24, 2009
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02320924
AIG Number0152508001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01BA14 LOTEPREDNOL
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LOTEPREDNOL ETABONATEActive
Strength: 0.2 % / W/V
Monograph: LOTEPREDNOL ETABONATE